$1.18 Billion is the total value of Eversept Partners, LP's 69 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HQY | New | HEALTHEQUITY INC | $24,728,594 | – | 338,516 | +100.0% | 2.09% | – |
| IBB | New | ISHARES TRput | $8,596,987 | – | 70,300 | +100.0% | 0.73% | – |
| TLT | New | ISHARES TRput | $8,310,253 | – | 93,700 | +100.0% | 0.70% | – |
| VRDN | New | VIRIDIAN THERAPEUTICS INC | $6,799,762 | – | 443,270 | +100.0% | 0.58% | – |
| HYG | New | ISHARES TRput | $6,634,800 | – | 90,000 | +100.0% | 0.56% | – |
| New | 2SEVENTY BIO INC | $5,697,242 | – | 1,453,378 | +100.0% | 0.48% | – | |
| TSHA | New | TAYSHA GENE THERAPIES INC | $5,390,246 | – | 1,705,774 | +100.0% | 0.46% | – |
| MRVI | New | MARAVAI LIFESCIENCES HLDGS I | $4,523,230 | – | 452,323 | +100.0% | 0.38% | – |
| PODD | New | INSULET CORP | $3,396,978 | – | 21,299 | +100.0% | 0.29% | – |
| AVTR | New | AVANTOR INC | $1,781,155 | – | 84,495 | +100.0% | 0.15% | – |
| BBIO | New | BRIDGEBIO PHARMA INCput | $1,471,446 | – | 55,800 | +100.0% | 0.12% | – |
| XBI | New | SPDR SER TRs&p biotech | $1,460,400 | – | 20,000 | +100.0% | 0.12% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.